Loading...
The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors
BACKGROUND: The BRAF(V600E) mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAF(V600E) mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. M...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3833185/ https://ncbi.nlm.nih.gov/pubmed/24228637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-11-291 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|